Infant and children's nutrition

DSM finishes sale of pharma assets to US firm

DSM finishes sale of pharma assets to US firm

By Hank Schultz

DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.

Follow us

Featured Events

View more

Products

View more

Webinars